Latest Breaking News On - Separation date - Page 1 : comparemela.com

Compass Therapeutics : 2024 Proxy Supplemental

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A Proxy.

United statesNeil lernerVered bisker leibThomas schuetzEllen chiniaraCarl gordonCompany board of directors theBoard of directors the companySecurities exchangeCompass therapeutics incCommission file numberExchange actCompany the separation agreementCompany onConsulting servicesStatement pursuant

Form DEF 14A Civeo Corp For: May 15

Form DEF 14A Civeo Corp For: May 15
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesMcclelland lakeNew york stock exchangeRice universityUnited kingdomSan jose state universityPerth and kinrossSoutheastern louisiana universityCity ofSwan hillsWest pointUnited kingdom generalBritish columbiaBlack diamondAlland schoening

Aileron Therapeutics : Management Change/Compensation - Form 8-K -March 29, 2024 at 08:05 am EDT

Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers;.

United statesSusanl drexlerCharles garnerBusiness assurance groupAileron therapeutics incCompany senior viceUniversity of michiganExchange commission as exhibitMerchant banking group of burrill companyBoard of directors the companyDanforth advisorsLung therapeutics incCompany registration statement on formBachelors of business administrationRecro pharma incCertain officers

Arcadia Biosciences (RKDA) Announces Resignation of Chief Marketing Officer Laura Pitlik

Arcadia Biosciences (RKDA) Announces Resignation of Chief Marketing Officer Laura Pitlik
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Laura pitlikArcadia biosciencesSeparation agreementSeparation date

Kristin Scott to Leave Abercrombie & Fitch Co as President, Global Brands and Managing Director, North America, Effective no Later Than March 30, 2024

On February 6, 2024, Abercrombie & Fitch Co. announced that on February 2, 2024, the company?s Board of Directors had determined to eliminate the role of President, Global Brands. As a result, Kristin.

United statesKristin scottAbercrombie fitch coGlobal brandsManaging directorNorth americaSeparation dateCurrent report